science
중도 성향
STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug
STAT News
조회 0
Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on Saturday. ...
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'science' 카테고리 뉴스
STAT의 다른 기사
STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending
STAT News
STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential
STAT News
Opinion: I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous action
STAT News